O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/2/2021ACC: 0001209191-21-006725
Officer· Chief Medical Officer
Since Jun 2018
+164.00
Net shares
Net buyer
$1.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
164.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+82.00
Price / share
$19.64
Trade value
$1.61K
% of position
2.5%
1/29/2021
3.26K→3.35K
Total
Net shares
+82.00
Net value
$1.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2021 | A · Award | +82.00 | $19.64 | $1.61K | 2.5% | 3.26K | 3.35K |
| Total | +82.00 | $1.61K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
82.00 shares
Shares
+82.00
Strike price
23.11
Held after
82.00
Exercisable
—
1/29/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock82.00 shares | 1/29/2021 | A · Award | +82.00 | 23.11 | — | 82.00 |